17.01.2020 • NewsAvantiumPeople

Avantium Appoints Bart Welten as Chief Financial Officer

Dutch renewables company Avantium has appointed Bart Welten as chief financial...
Dutch renewables company Avantium has appointed Bart Welten as chief financial officer (CFO), effective January 2020. Source: Avantium

Dutch renewables company Avantium has appointed Bart Welten as chief financial officer (CFO), effective January 2020.

Welten has 30 years of experience in finance and extensive knowledge of the chemical and life-sciences industries. Prior to joining Avantium he was CFO of Centrient Pharmaceuticals, the former joint venture of DSM and Sinochem in Singapore. Welten also served as CFO of DSM Resins and DSM Anti-Infectives. He holds a law degree from Leiden University, Netherlands and an MBA from Boston College, USA.

Tom van Aken, CEO of Avantium said: “We are delighted to welcome Bart to Avantium as our new CFO. He brings a wealth of international finance and managerial experience, and we are confident that he will make a very important contribution to Avantium and help enable us to deliver our strategic objectives.”

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.